CIA
AMPE

Capital Impact Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Capital Impact Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-76
Closed -$79K – 314
2014
Q4 		$79K Hold
76
– – 0.04% 213
2014
Q3 		$81 Hold
76
– – ﹤0.01% 214
2014
Q2 		$191K Buy
+76
New +$155K 0.14% 95

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Capital Impact Advisors's AMPE Position: Q1 2015 in Review

Capital Impact Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2015, closing a stake of 76 shares — an estimated $79K sold.

Capital Impact Advisors first reported a position in AMPE in Q2 2014 and held it in 3 quarters. The position peaked at $191K in Q2 2014. 75 funds tracked by Wall St. Rank hold AMPE as of Q1 2015.

  • Capital Impact Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2015 after selling out during the quarter.
  • Capital Impact Advisors sold 76 Ampio Pharmaceuticals Inc. shares in Q1 2015, an estimated $79K.
  • Capital Impact Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 3 quarters.
  • Capital Impact Advisors's Ampio Pharmaceuticals Inc. position peaked at $191K in Q2 2014.
  • 75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2015.

Based on Capital Impact Advisors's 13F filing for Q1 2015, filed 29 May 2015.